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TGFb1 INCREASES OXIDATIVE STRESS IN HUMAN OSTEOARTHRITIS
ARTICULAR CHONDROCYTES THROUGH MECHANISMS INVOLVING
NOX4
L. Lugo y, G. Herrero-Beaumont y, S.A. JImenez z, S. Piera-
Velazquez z. y IIS-Fundación Jiménez Díaz, Madrid, Spain; z Thomas
Jefferson Univ., Philadelphia, PA, USA
Purpose. Oxidative stress plays an important role in articular cartilage
in osteoarthritis (OA). Although reactive oxygen species (ROS) are key
components of numerous normal physiological processes in chon-
drocytes, ROS overproduction results in oxidative stress causing chon-
drocyte death and matrix degradation. NADPH oxidases such as NOX4
play a major role in ROS production. It has been described that TGFb1
increases cartilage cellular ROS levels, exhibiting a pro-oxidant effect.
However, TGFb1 regulation of NOX4 and the role of NOX4 in articular
cartilage have not been fully elucidated. Here, we characterized NOX4
participation in TGFb1-induced oxidative stress increase in human
articular chondrocytes and evaluated its possible role in articular
cartilage pathology.
Methods. Human OA articular cartilage chondrocytes were cultured
with or without TGFb1 (10ng/ml) and the role of NOX4 was assessed by
examining the effects of a speciﬁc NOX4 inhibitor (10mM). Total ROS
production was determined following 5h incubation with TGFb1 alone
or in combination with the speciﬁc NOX4 inhibitor using a superoxide-
sensitive ﬂuorescent dye. NOX4 expression was evaluated by semi-
quantitative real-time PCR after 24h incubation with or without TGFb1.
The intracellular kinases involved were examined employing the
following speciﬁc kinase inhibitors: 10 mM SB431542 (smad2/3 inhib-
itor), 5mMLY194002 (PI3kinase inhibitor) or 3 mMSI3 (smad3 inhibitor).
To study the direct effects of NOX4 overexpression in chondrocytes, the
cells were incubated for 24h with a pLentiviral expression vector which
up-regulates NOX4 or with an empty lentiviral construct as a control
and the expression of NOX4, COL1, COL2, COL10, AGGR, COMP, SOX9 and
TWIST1 was assessed by semi-quantitative real-time PCR.
Results. TGFb1 caused stimulation of total ROS production compared
with non-treated cells as assessed by ﬂuorescence microscopy. These
effects were mediated by NOX4 as they were abrogated by the speciﬁc
NOX4 inhibitor. Gene expression studies indicated a potent upregula-
tion of NOX4 by TGFb1. The kinase inhibitory studies demonstrated that
the speciﬁc smad2/3 inhibitor SB431542 was the only inhibitor that
caused a decrease of NOX4 stimulation induced by TGFb1. In contrast
SI3, a speciﬁc smad3 inhibitor did not cause any effect. The lentiviral
construct-induced up regulation of NOX4 produced a signiﬁcant
reduction in AGGR expression levels.
Conclusion. TGFb1 causes a marked increase in oxidative stress in
human OA chondrocytes that is mediated by elevated expression of
NOX4. The increase in NOX4 expression involves a smad2 dependent
mechanism. The increased levels of ROS mediated by increased NOX4
caused a reduction of aggrecan gene expression. The results indicate
that TGFb1 may cause deleterious effects on human articular chon-
drocytes owing to a NOX4-mediated potent stimulation of ROS
production and that speciﬁc NOX4 inhibition may be beneﬁcial for
human OA.
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IDENTIFICATION AND CHARACTERISATION OF NOVEL MICRORNAS
INVOLVED IN OSTEOARTHRITIS
N. Crowe y, T.E. Swingler y, L. Le y, K. Sorefan y, H. Pais y, M.J. Barter z, S.T.
Donell y, D.A. Young z, T. Dalmay y, I.M. Clark y. yUniv., of East Anglia,
Norwich, United Kingdom; zNewcastle Univ., Newcastle, United KingdomPurpose: Osteoarthritis is a painful and debilitating disease charac-
terised by loss of cartilage, aberrant gene expression and bone
remodelling. MicroRNAs are very small, 20-24 nucleotide non-coding
RNA molecules that post-transcriptionally regulate gene expression.
There is evidence to suggest that they can affect chondrogenesis and
both the initiation and progression of osteoarthritis, however the exact
mechanisms are still mostly undetermined. In this study we discovered
novel microRNAs, using next generation deep sequencing, with a role in
chondrogenesis and osteoarthritis, and subsequently elucidate their
function.
Methods: Novel microRNAs expressed in human osteoarthritic articular
cartilage were identiﬁed using deep sequencing with Illumina's GAIIX
system and validated in primary chondrocyte culture in vitro using real
time PCR. Expression of the novel microRNAs were also measured in
chondrogenesis assays and across diverse human tissues. Northern
blotting was utilised to validate size of novel microRNAs, and bio-
informatics analysis was employed in initial target searches to establish
function. An Illumina total genome microarray will be used alongside
the bioinformatics data to conﬁrm microRNA targets and thereby
elucidate function.
Results: Deep sequencing of the small RNA pool from chondrocytes
extracted from primary human osteoarthritic cartilage identiﬁed
w1600 completely novel miRNAs. Sixteen of these have been validated
in cultured primary human chondrocytes and across a human tissue
panel using qRT-PCR. Three novel microRNAs were proven by northern
blotting to be of correct size. A bioinformatics target search using
RStudios combined with freely available online software has shown
a range of targets for these three such as IL6ST, CD44, andMMP16which
are known to be involved in osteoarthritis and chondrocyte
development.
Conclusions: The entire microRNA population of cartilage is still not
fully determined, however the sequencing used in this project provided
substantially less bias than many deep sequencing experiments. We
found a number of novel microRNAs to be regulated during chondro-
genesis and to have differential expression between osteoarthritic and
non-diseased articular cartilage tissue. Potential targets such as IL-6ST
and CD44 further suggest a role in osteoarthritis or chondrogenesis. The
signiﬁcant number of novel microRNAs discovered and their subse-
quent validation provides new insights into how microRNAs may
regulate both cartilage homeostasis and contribute to osteoarthritis.59
INDUCIBLE CARTILAGE-SPECIFIC PPARGAMMA-DEFICIENT MICE
EXHIBIT ACCELERATED EXPERIMENTALLY-INDUCED OSTEOARTHRITIS
ASSOCIATEDWITH DEFECTIVE AUTOPHAGYAND mTOR SIGNALING
F. Vasheghani, Y. Zhang, J.-P. Pelletier, J. Martel-Pelletier,
M. Kapoor. Univ. of Montreal, Montreal, QC, Canada
Purpose: Our previous studies showed that germ-line PPAR-g knockout
(KO) mice exhibit cartilage and bone developmental defects and during
aging they exhibit spontaneous cartilage degradation. To bypass these
developmental defects associated with germ-line PPARg KOmice, in the
present study we generated inducible-cartilage-speciﬁc PPARg KOmice
and subjected these mice to destabilization of medial meniscus (DMM)
model of osteoarthritis (OA). The main objective of this study was to
identify the speciﬁc in vivo role of PPARg in OA using DMM murine
model.
Methods: Inducible cartilage-speciﬁc PPARg KO mice were generated
using the LoxP/Cre system in which Cre expression was induced by
doxycycline treatment in 4 weeks old mouse. 10 weeks old mice were
subjected to DMM model of OA.
Results:Histomorphometric analysis ofmice knee joints 5 and 10weeks
post OA surgery showed that inducible cartilage-speciﬁc PPARg KOmice
when compared to WT mice, exhibited accelerated OA (signiﬁcantly
increased OARSI histopathological scoring) associated with enhanced
cartilage degradation, hypocellularity, synovial inﬂammation, mono-
nuclear cell inﬂux and increased expressionof catabolic factors (MMP-13
and ADAMTS-5, accompanied by decrease in the expression of aggrecan
and type II collagen. Our results also showed that PPARg deﬁcient
cartilage exhibited enhanced expression of mammalian target of rapa-
mycin (mTOR) associated with decreased expression of autophagy
speciﬁc genes includingULK1 (most up streamautophagy inducer), LC3B
(critical factor for autophagy vacuole formation) and ATG5 (required for
autophagosome formation). Treatment of PPARg deﬁcient chondrocytes
Table 1
Demographic, WOMAC total, Kellgren Lawrence grades, walking speed and muscle
strength
Variable No-TKA TKA P Value
Age (years) 58 (8) 59 (10) 0.49
Mass (kg) 93.8 (18.8) 93.5 (13.5) 0.95
BMI (kg/m2) 30.8 (5.3) 30.6 (4.8) 0.92
WOMAC (Total) 29.0 (20.4) 36.8 (14.6) 0.14
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collagen and downregulated the expression of MMP-13 and ADAMTS-5.
Interestingly, PPARg plasmid was able to rescue the expression of
autophagy-speciﬁc genes (ULK1, LC3B and ATG5) and downregulate
mTOR expression in PPARg deﬁcient.
Conclusion: Loss of PPARg in the cartilage and subsequent increase in
mTOR expression and decreased autophagy signalling could be
responsible for decreased chondroprotection and accelerated cartilage
degradation.KL Distribution 2 KL1
10 KL2
11
KL3
2 KL4
3 KL1
6 KL2
12
KL3
4 KL4
Walking Velocity 1.27 (0.22) 1.23 (0.16) 0.42
Knee Extension (Nm) 123.8 (42.0) 113.6 (41.7) 0.40
Knee Flexion (Nm) 60.0 (24.3) 56.6 (25.8) 0.64
Plantar ﬂexion (Nm) 98.2 (37.1) 84.9 (30.2) 0.1860
MUSCLE ACTIVATION DIFFERENCES DURING WALKING BETWEEN
THOSE WITH MODERATE KNEE OSTEOARTHRITIS WHO PROGRESS
TO TOTAL KNEE ARTHROPLASTY AND THOSE THAT DO NOT:
A FOLLOW UP STUDY
C.L. Hubley-Kozey, G. Hatﬁeld, W.D. Stanish. Dalhousie Univ., Halifax, NS,
Canada
Purpose: While muscle activation patterns during walking show that
differences are speciﬁc to disease severity, whether pattern differences
are related to progression have not been examined. This follow up study
tested two hypotheses: i) that knee extensor, knee ﬂexor and plantar
ﬂexor strength will be lower and ii) muscle activation patterns (same
muscle groups) will have higher with more prolonged activity during
walking in those at baseline diagnosed with medial compartment knee
OA who at 8 year follow up had progressed to a total knee arthroplasty
(TKA) and those that did not.
Methods: 50 participants with moderate medial compartment knee
OA were tested at baseline. WOMAC scores were recorded and stan-
dard anterior posterior radiographs were graded using the Kellgren
Lawrence grading scale. Strength testing consisted of maximum
voluntary isometric contraction (MVIC) exercises on an isokinetic
dynamometer for plantar ﬂexors, knee extensors and ﬂexors. Torque
was calculated for each exercise as the peak 1 second steady state
amplitude from two trials (Nm). Surface electromyograms (EMG) were
sampled at 2000 Hz from 7 sites (vastus lateralis/medialis, rectus
femoris, lateral/medial hamstrings and lateral/medial gastrocnemius
muscles) using a standardized protocol during the exercises and while
participants walked at their self-selected speed. EMG waveforms were
averaged for 5 trials, time-normalized to percent of gait cycle and
amplitude-normalized to %MVIC. EMG waveform amplitude and
temporal characteristics were determined using Principal Component
Analysis (PCA). At follow up (mean 7.8 years), 25 patients reported
undergoing TKA surgery. Unpaired Student's t-tests examined differ-
ences in baseline demographic, symptoms, walking velocity and
muscle strength between groups (a¼0.05). Two factor (group, muscle)
analysis of variance models tested for signiﬁcant interactions and main
effects for waveform characteristics (PC scores) within each muscle
group.
Results: There were no between-group differences (p>0.05) in age,
body mass index, gait speed, WOMAC or muscle strength measures
(Table 1). The No-TKA group had 17 males and the TKA group had 19
males. Radiographic disease severity distribution was similar between
groups at baseline (Table 1). Signiﬁcant group main effects were found
for PC1 (overall amplitude) for all muscles and PC2 (prolonged activa-
tion) for the quadriceps and hamstrings (p<0.05). See ﬁgure 1. The TKA
group had signiﬁcantly higher overall activity of all muscles at baseline
(PC1, p<0.05) compared to the group that did not. The TKA group also
had prolonged stance phase activity of quadriceps and hamstrings (PC2,
p<0.05) at baseline.
Conclusions: Despite similar anthropometrics, structural impairment,
symptoms, walking velocity and muscle strength, the group that
progressed to TKA had higher hamstrings and quadriceps activity
throughout the gait cycle, with prolonged activity during mid-stance
indicative of higher co-activation. In contrast to OA severity ﬁndings,
the gastrocnemius activity increased. This combination of patterns in
the TKA group is consistent with increased risk of compressive loading
on the knee joint and increased risk of muscle fatigue. Furthermore
they provide clinical ﬁndings that support animal experimental
models that showed increased muscle co-activation was related to OA
progression through increased joint compressive loads. This novel
longitudinal study provides evidence that muscle activation patterns
during gait, not just muscle strength deﬁcits are related to knee OA
progression.Ă61
OARSI RECOMMENDED PERFORMANCE-BASED TESTS TO ASSESS
PHYSICAL FUNCTION IN PEOPLE WITH ESTABLISHED HIP AND
KNEE OSTEOARTHRITIS
F. Dobson y, R.S. Hinman y, E.M. Roos z, J.H. Abbott x, P. Stratford k,
A. Davis {, R. Buchbinder #, L. Snyder-Mackler yy, Y. Henrotin zz,
J. Thumboo xx, K.L. Bennell y. y The Univ. of Melbourne, Victoria,
Australia; zUniv. of Southern Denmark, Odense, Denmark; xUniv. of
Otago, Dunedin, New Zealand; kMcMaster Univ., Hamilton, ON, Canada;
{ Toronto Western Res. Inst., Toronto, ON, Canada; #Monash Univ.,
Victoria, Australia; yyUniv. of Delaware, Newark, DE, USA; zzUniv. of
Liège, Liège, Belgium; xx Singapore Gen. Hosp., Singapore, Singapore
Purpose: Currently, there are no international recommendations on
which performance-based measures of physical function should be
used to measure outcomes in people with hip and knee osteoarthritis
(OA). The aim of this project was to identify a consensus-derived set of
performance-based tests of physical function for people with estab-
lished hip and/or knee OA.
Methods: An overview of the methodology is outlined in Figure 1. An
international, multidisciplinary expert advisory group was established
to guide the study. Candidate tests for the recommend set were iden-
tiﬁed by a survey of the advisory group and a systematic review of the
measurement properties of performance-based tests in people with
established hip and knee OA. Candidate tests were grouped into activity
themes by the advisory group. A multi-phase, consensus-based
approach was used to prioritize and select performance-based tests by
applying decision analysis methodology (1000Minds) to a series of
online surveys. Surveys ranked the difﬁculty and the feasibility of
